Company Profile

Vivakor Inc (AKA: Genecular Holdings LLC)
Profile last edited on: 12/19/2018      CAGE: 511B8      UEI: PBLFBLAJ6619

Business Identifier: Asset acquisition
Year Founded
2006
First Award
2009
Latest Award
2009
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8565 South Eastern Avenue Suite 150
Las Vegas, NV 89123
   (949) 281-2606
   info@vivakor.com
   www.vivakor.com
Location: Single
Congr. District: 03
County: Clark

Public Profile

Formerly known until 2008 as Genecular Holdings LLC, Vivakor, Inc.(OTC:VIVK) is a cross-disciplinary biomedical company addressing discovery, development, and commercialization of a range of medical devices and pharmaceuticals to improve human health. It is best perhaps understood as a holding company specializing in developing assets, start-ups, technology and growth sector specialty companies. The company holds interest in the areas of imaging technology for MRI’s, natural supplements, and other areas. It also holds technologies in solar energy for personal portable use, sports mountain technology, and proprietary concepts. In addition, the company holds an option to acquire an interest in mining claims and technology for the extraction of precious metals, including gold, silver, platinum, and rare earth minerals located in Arizona and Colorado; and in Vapor Technology for the processing of precious metals. Further, it develops VivaBlend and VivaBoost nutraceutical/supplement space bioactive beverages. Additionally, the company develops cancer detection, wound healing, cryogenic preservation, and storage drugs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : VIVK
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2009 1 NIH $112,912
Project Title: Development of a Digital Photorefractor to Detect Amblyogenic Risk Factors

Key People / Management

  Matt Nicosia -- Chair and CEO

  Tannin J Fuja

  David Kovacs

  Lou Lopez -- Executive Vice President

  Tyler Nelson -- Chief Financial Officer

Company News

There are no news available.